Premium
Wilson's disease: resolution of MRI lesions following long‐term oral zinc therapy
Author(s) -
Huang C.C.,
Chu N.S.
Publication year - 1996
Publication title -
acta neurologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.967
H-Index - 95
eISSN - 1600-0404
pISSN - 0001-6314
DOI - 10.1111/j.1600-0404.1996.tb00203.x
Subject(s) - dysarthria , magnetic resonance imaging , dystonia , basal ganglia , pons , brainstem , medicine , thalamus , akinetic mutism , midbrain , wilson's disease , nuclear medicine , radiology , psychology , disease , pathology , central nervous system , psychiatry
A 28‐year‐old man with Wilson's disease developed neurological deterioration after a low‐dose of d‐penicillamine treatment for 2 weeks. He showed an akinetic rigid syndrome with generalized dystonia. Brain magnetic resonance images (MRI) on T 2 and proton weighted images showed an increased signal intensity over the thalamus, basal ganglia and brainstem, especially the midbrain and pons. After treatment had been changed to zinc sulphate, the akinetic‐rigid syndrome and dystonia were improved slowly in the following 4 years. Serial MRI studies showed a gradual resolution of the lesions. His current neurological status was almost normal except for dysarthria and mild intention tremor.